# FDA 483 - North Louisiana Tissue Bank - September 24, 2021

Source: https://www.keypedia.com/records/483/north-louisiana-tissue-bank/33936fd0-411c-4643-8e8a-a81fe4f0e91a

> FDA 483 for North Louisiana Tissue Bank on September 24, 2021. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: North Louisiana Tissue Bank
- Inspection Date: 2021-09-24
- Product Type: biologics
- Office Name: New Orleans District Office
- Summary: An FDA inspection of North Louisiana Tissue Bank in West Monroe, LA, revealed a significant deficiency in their tracking system for Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps). The firm failed to establish a system to track HCT/Ps to final disposition, specifically for discarded tissues. This resulted in nine discarded tissues lacking final disposition records due to unrevised and unimplemented donor procedures.

## Related Officers

- [Juanelma H. Palmer](https://www.keypedia.com/people/juanelma-h-palmer/db3e79b5-d2d4-46d8-a075-4674dbc8c3d0)

Company: https://www.keypedia.com/companies/north-louisiana-tissue-bank/661d9e31-71be-43ad-92eb-c8b5acdff21a

Office: https://www.keypedia.com/offices/new-orleans-district-office/95352142-b992-4e06-849d-d7483c0959ea